Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2019

May 15, 2019

34412_dirs_2019-05-15_c5f5065f-02cc-4198-bf48-6b39d0aef16d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2019-05-13

Reporting Person: Klickstein Lloyd (Chief Scientific Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-13 Stock Option (Right to Buy) $8.08 A 295000 Acquired 2029-05-12 Common Stock (295000) Direct

Footnotes

F1: 25% of the shares shall vest on May 13, 2020, and the remaining shares shall vest in 12 equal quarterly installments thereafter.